Linde plc
Linde Reports Strong 2025 Financial Results and 2026 Guidance
Summary
On February 5, 2026, Linde plc reported strong financial results for the quarter and year ended December 31, 2025. Full-year sales were $34.0 billion, up 3% YoY, with underlying sales up 2%. Operating profit was $8.9 billion and adjusted operating profit was $10.1 billion, both up 4%. Diluted EPS was $14.61 and adjusted diluted EPS was $16.46, up 6%. For 2026, the company expects adjusted diluted EPS to be in the range of $17.40 to $17.90, up 6% to 9% YoY or 5% to 8% excluding currency tailwinds. First-quarter 2026 adjusted EPS guidance is $4.20 to $4.30, up 6% to 9% YoY or 3% to 6% excluding currency tailwinds.
Profitelligence Alerts
Get alerts for LIN
Be first to know when Linde plc files with the SEC.
Filing Categories
Advertisement
About Linde plc
Linde plc is a multinational industrial gas and engineering company that plays a pivotal role in various sectors by providing essential gases and services. The company engages in the production and supply of industrial, process, and specialty gases, which are crucial for diverse industries including healthcare, manufacturing, food and beverage, electronics, and energy. Linde's offerings aid in improving efficiency, reducing emissions, and enhancing productivity across these sectors. With a heritage dating back to 1879 and its current domicile in the United Kingdom, Linde has firmly established itself as a global leader through continuous innovation and strategic expansion. The company's extensive portfolio includes atmospheric gases like oxygen, nitrogen, and argon, as well as hydrogen and helium, supporting critical operations from steel manufacturing to water treatment and medical applications. Linde's significance in the market is underscored by its widespread geographical reach and strong commitment to sustainable practices and technological advancements, further reinforcing its crucial role in supporting sustainable industrial development worldwide.
Official SEC Documents
Advertisement